Authors: Ahmad Fairuzabadi Mohd Mansor 1 ; Anis Nordin 1 ; Kian Liang Goh 2 ; Soon Hin How 2 ; Yumi Zuhanis Has-Yun Hashim 3 and Mardhiah Mohammad 4

Affiliations: 1 Kulliyyah of Engineering, International Islamic University Malaysia (IIUM), Jalan Gombak, Kuala Lumpur and Malaysia ; 2 Kulliyyah of Medicine, IIUM Kuantan and Malaysia ; 3 International Institute for Halal Research and Training (INHART), IIUM Gombak and Malaysia ; 4 Kulliyyah of Allied Health Science, IIUM Kuantan and Malaysia

Keyword(s): ECIS; Impedance Biosensing System; Lung Cancer; Chemosensitivity;

Abstract: Cancer treatment, especially chemotherapy can cause very painful side effects such as nausea, fatigue, diarrhoea and nerve damage. Efficient treatment of cancer is when the most appropriate drug and dosage is given to patients' such that it increases their disease-free survival rates but minimizes pain. Currently, oncologists subject cancer patients to a standard chemotherapeutic regimen based on the type and grade of tumour. However, tumour behaviours are unpredictable and are often different for each individual patient. Personalized studies predicting a patient's response to chemotherapeutic treatment are rarely done since it involves tedious end-point measurements and drug preparation. Usage of personalized biosensors, where cultured cancer cells from each patient are tested with different chemotherapy agents can change this. This allows clinicians to predict the best chemotherapy agent or combination of agents that are likely to be successful against the patient’s tumours without subjecting patients to ineffective therapy, increasing clinical response and minimizing adverse effects. In this research, a biosensing system based on Electrical Cell-Substrate Impedance Sensing (ECIS) concept will be designed and developed to monitor adhesion, proliferation and death of cancer cells in vitro due to exposure to chemotherapy drugs. Chemosensitivity analysis will be performed using the developed impedance biosensing system by correlating the response of cell samples towards several chemotherapy regimens. A comparison will be made between tests conducted using biosensors and the actual chemotherapy treatment prescribed to patients. (More)

PDF ImageFull Text


Sign In Guest: Register as new SciTePress user now for free.

Sign In SciTePress user: please login.

PDF ImageMy Papers

You are not signed in, therefore limits apply to your IP address

In the current month:
Recent papers: 100 available of 100 total
2+ years older papers: 200 available of 200 total

Paper citation in several formats:
Mohd Mansor, A.; Nordin, A.; Goh, K.; How, S.; Hashim, Y. and Mohammad, M. (2019). Design and Development of Parallel Biosensing System for Personalized Chemotherapy Treatment.In Doctoral Consortium - Volume 1: DCBIOSTEC, ISBN , pages 15-19

author={Ahmad Fairuzabadi Mohd Mansor. and Anis Nordin. and Kian Liang Goh. and Soon Hin How. and Yumi Zuhanis Has{-}Yun Hashim. and Mardhiah Mohammad.},
title={Design and Development of Parallel Biosensing System for Personalized Chemotherapy Treatment},
booktitle={Doctoral Consortium - Volume 1: DCBIOSTEC,},


JO - Doctoral Consortium - Volume 1: DCBIOSTEC,
TI - Design and Development of Parallel Biosensing System for Personalized Chemotherapy Treatment
SN -
AU - Mohd Mansor, A.
AU - Nordin, A.
AU - Goh, K.
AU - How, S.
AU - Hashim, Y.
AU - Mohammad, M.
PY - 2019
SP - 15
EP - 19
DO -

Login or register to post comments.

Comments on this Paper: Be the first to review this paper.